(Q37468681)

20 August 2017

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer (English)

1 reference

Ana Maria Gonzalez-Angulo

20 August 2017

1 reference

W Woodward

9

0 references

14

object named as

A M Gonzalez-Angulo

1 reference

20 August 2017

C Liedtke

1

1 reference

20 August 2017

K Broglio

2

1 reference

20 August 2017

S Moulder

3

1 reference

20 August 2017

L Hsu

4

1 reference

20 August 2017

S-W Kau

5

1 reference

20 August 2017

W F Symmans

6

1 reference

20 August 2017

C Albarracin

7

1 reference

20 August 2017

F Meric-Bernstam

8

1 reference

20 August 2017

R L Theriault

10

1 reference

20 August 2017

L Kiesel

11

1 reference

20 August 2017

G N Hortobagyi

12

1 reference

20 August 2017

L Pusztai

13

1 reference

20 August 2017

language of work or name

1 reference

12 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

20

1 reference

20 August 2017

12

1 reference

20 August 2017

1953-1958

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Gene expression profiles of primary breast tumors maintained in distant metastases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Molecular portraits of human breast tumours

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Stability of HER-2/neu expression over time and at multiple metastatic sites

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Growth dominance of the metastatic cancer cell: cellular and molecular aspects

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

erbB-2 (HER-2) and breast cancer progression.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791352

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

2 September 2018

1 reference

12 December 2020

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

12 December 2020

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

12 December 2020

Marked Intratumoral Heterogeneity of the Proto-Oncogene Her-2/neu Determined by Three Different Detection Systems

1 reference

12 December 2020

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

12 December 2020

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

12 December 2020

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

12 December 2020

Nuclear structure in cancer tissues

1 reference

12 December 2020

HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process

1 reference

12 December 2020

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

1 reference

12 December 2020

Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDP263

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19596702

1 reference